Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Zeltiq Aesthetics, MGH Initiate Patent Lawsuit Against Clinipro - Quick Facts

RELATED NEWS
Trade ZLTQ now with 

Medical technology company Zeltiq Aesthetics, Inc. (ZLTQ: Quote) and the charitable trust of Massachusetts General Hospital or MGH initiated a patient infringement lawsuit in France against Clinipro and its French representative.

In its suit, Zeltiq alleged infringement of a European patent for CoolSculpting technology owned by Massachusetts General Hospital and licensed to Zeltiq and sought monetary damages and an injunction against further sales of Clinipro's LipoCryo device. Zeltiq said the CoolSculpting technology is protected by numerous patents and trademarks around the world.

Click here to receive FREE breaking news email alerts for ZELTIQ Aesthetics, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.